Zenón Frances, Segarra Annabell C, Gonzalez Mariangeline, Meléndez Loyda M
Department of Microbiology and Medical Zoology, School of Medicine, University of Puerto Rico Medical Sciences Campus, PO Box 365067, San Juan, Puerto Rico.
J Neuroimmune Pharmacol. 2014 Dec;9(5):703-15. doi: 10.1007/s11481-014-9563-z. Epub 2014 Sep 11.
Substance abuse is a risk factor for HIV infection and progression to AIDS. Recent evidence establishes that cocaine use promotes brain perivascular macrophage infiltration and microglia activation. The lysosomal protease cathepsin B is increased in monocytes from patients with HIV dementia and its secretion induces 10-15% of neurotoxicity. Here we asked if cocaine potentiates cathepsin B secretion from HIV-infected monocyte-derived macrophages (MDM) and its effect in neuronal apoptosis. Samples of plasma, CSF, and post-mortem brain tissue from HIV positive patients that used cocaine were tested for cathepsin B and its inhibitors to determine the in vivo relevance of these findings. MDM were inoculated with HIV-1ADA, exposed to cocaine, and the levels of secreted and bioactive cathepsin B and its inhibitors were measured at different time-points. Cathepsin B expression (p < 0.001) and activity (p < 0.05) increased in supernatants from HIV-infected cocaine treated MDM compared with HIV-infected cocaine negative controls. Increased levels of cystatin B expression was also found in supernatants from HIV-cocaine treated MDM (p < 0.05). A significant increase in 30% of apoptotic neurons was obtained that decreased to 5% with the specific cathepsin B inhibitor (CA-074) or with cathepsin B antibody. Cathepsin B was significantly increased in the plasma and post-mortem brain tissue of HIV/cocaine users over non-drug users. Our results demonstrated that cocaine potentiates cathepsin B secretion in HIV-infected MDM and increase neuronal apoptosis. These findings provide new evidence that cocaine synergize with HIV-1 infection in increasing cathepsin B secretion and neurotoxicity.
药物滥用是感染艾滋病毒并发展为艾滋病的一个风险因素。最近的证据表明,使用可卡因会促使脑周血管巨噬细胞浸润和小胶质细胞激活。溶酶体蛋白酶组织蛋白酶B在患有艾滋病毒痴呆症患者的单核细胞中含量增加,其分泌会诱发10 - 15%的神经毒性。在此,我们探究了可卡因是否会增强艾滋病毒感染的单核细胞衍生巨噬细胞(MDM)中组织蛋白酶B的分泌及其对神经元凋亡的影响。对使用可卡因的艾滋病毒阳性患者的血浆、脑脊液和死后脑组织样本进行组织蛋白酶B及其抑制剂检测,以确定这些发现的体内相关性。用HIV - 1ADA感染MDM,使其暴露于可卡因中,并在不同时间点测量分泌型和生物活性组织蛋白酶B及其抑制剂的水平。与感染艾滋病毒的可卡因阴性对照相比,感染艾滋病毒且经可卡因处理的MDM上清液中组织蛋白酶B的表达(p < 0.001)和活性(p < 0.05)增加。在感染艾滋病毒且经可卡因处理的MDM上清液中还发现胱抑素B表达水平升高(p < 0.05)。凋亡神经元显著增加了30%,而使用特异性组织蛋白酶B抑制剂(CA - 074)或组织蛋白酶B抗体后,这一比例降至5%。与未使用药物者相比,艾滋病毒/可卡因使用者的血浆和死后脑组织中组织蛋白酶B显著增加。我们的结果表明,可卡因会增强艾滋病毒感染的MDM中组织蛋白酶B的分泌并增加神经元凋亡。这些发现提供了新的证据,表明可卡因与艾滋病毒 - 1感染协同作用,增加组织蛋白酶B的分泌和神经毒性。